Manufacturing And Sustainability

  1. Three Novel Protein Therapeutic Worldviews 9/13/2024

    In this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics, we meet panelists who share their topline perspectives on developing complex, novel protein therapeutics.

  2. Where Process Intensification Sits In The AbbVie, AstraZeneca Organizations 8/27/2024

    In this segment of the Bioprocess Online Live event Bioprocess Intensification In The Real World, panelists discuss where and how their roles in setting the course for process intensification sit within their greater organizations.

  3. Master The 2-Point Calibration Process To Maintain Data Integrity 5/19/2025

    Ensure accurate sensor readings with an innovative software by mastering the 2-point calibration process. Learn more about how and why regular calibration supports data integrity and compliance.

  4. Why AstraZeneca and AbbVie Are Intensifying Processes 8/27/2024

    In this segment of the Bioprocess Online Live event Bioprocess Intensification In The Real World, our speakers share the motivation for continued process intensification in their respective organizations.

  5. Accelerating mAb Process Development In The Growing Therapeutics Market 8/20/2024

    The market for mAbs and mAb variants is growing rapidly. Explore the latest strategies and advancements in early stage mAb up- and downstream process development.

  6. Advances In Flow-Through Technology To Enhance mAb Polishing 5/27/2025

    Walk through three case studies that illustrate how novel chromatographic tools can improve the purification process for complex therapeutics by reducing aggregates and HCPs and effectively clearing retroviruses.

  7. mAb Up- And Downstream Process Intensification Strategies 12/12/2024

    Discover how to reduce monoclonal antibody (mAb) manufacturing time and costs through process intensification. Learn about continuous perfusion, ultrahigh cell density banks, and more.

  8. Advanced Granulation Technology (AGT) Cell Culture 11/4/2019

    This video is an overview of the most advanced media format available for cell culture - AGT.  A granular dry media format produced through a technologically advanced process which allows manufacturing of complete formulations in a dry format. It can be used in both fed-batch and perfusion cell cultures. AGT dry media is ready-to-use at target pH and osmolality. It is available in complete serum-free, protein-free and chemically-defined media formulations

  9. Dry Powder Media Manufacturing Grand Island Expansion 11/5/2025

    Take a video tour of our newly expanded dry powder media manufacturing facility in Grand Island, New York. The expansion has added more than 45,000 square feet of Animal Origin Free (AOF) manufacturing space to help meet increasing global demand.

  10. A Collaboration With Zurich University Of Applied Sciences 5/19/2025

    Explore ZHAW’s pioneering work and collaboration in cell cultivation and bioprocessing to deliver scalable, high-performance solutions that address key challenges in biomanufacturing scale-up.